[1]
|
Lapeyssonnie, L. (1963) Cerebrospinal meningitis in Africa (in French). Bulletin of the World Health Organ, 28, 1-114.
|
[2]
|
Greenwood, B. (1999) Manson lecture: Meningococcal meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 341-353.
doi:10.1016/S0035-9203(99)90106-2
|
[3]
|
Molesworth, A.M., Thomson, M.C., Connor, S.J., Cresswell, M.P., et al. (2002) Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 96, 242-249.
doi:10.1016/S0035-9203(02)90089-1
|
[4]
|
World Health Organization (1998) Control of epidemic meningococcal disease. WHO practical guidelines. 2nd Edition, WHO, Geneva.
|
[5]
|
Schuchat, A., Robinson, K., Wenger, J.D., Harrison, L.H., et al. (1997) Bacterial meningitis in the United States in 1995. The New England Journal of Medicine, 337, 970-976. doi:10.1056/NEJM199710023371404
|
[6]
|
Broome, C.V., Rugh, M.A., Yada, A.A., Giat, L., et al. (1983) Epidemic group C meningococcal meningitis in Upper Volta, 1979. Bulletin of the World Health Organ, 61, 325-330.
|
[7]
|
Koumare, B., Bougoudogo, F., Cisse, M., Doumbia, T., et al. (1993) Bacteriological aspects of purulent meningitis in Bamako district: A propos of 1541 bacterial strains collected from 1979 to 1991 (in French). Bulletin de la Société de Pathologie Exotique, 86, 136-140.
|
[8]
|
Parent du Chatelet, I., Traore, Y., Gessner, B.D., Antignac, A., et al. (2005) Bacterial meningitis in Burkina Faso: Surveillance using field-based polymerase chain reaction testing. Clinical Infectious Diseases, 40, 17-25.
doi:10.1086/426436
|
[9]
|
World Health Organization (2002) Meningococcal disease, serogroup W135, Burkina Faso: Preliminary report, 2002. Weekly Epidemiological Record, 77, 152-155.
|
[10]
|
Campagne, G., Schuchat, A., Djibo, S., Ousseini, A., et al. (1999) Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. Bull World Health Organ, 77, 499-508.
|
[11]
|
Etienne, J., Sperber, G., Adamou, A. and Picq, J.J. (1990) Epidemiological notes: Meningococcal meningitis of serogroup X in Niamey (Niger) (in French). Médecine Tropicale, 50, 227-229.
|
[12]
|
Djibo, S., Nicolas, P., Alonso, J.M., Djibo, A., et al. (2003) Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000. Tropical Medicine & International Health, 8, 1118-1123.
doi:10.1046/j.1360-2276.2003.01126.x
|
[13]
|
Gagneux, S.P., Hodgson, A., Smith, T.A., Wirth, T., et al. (2002) Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. The Journal of Infectious Diseases, 185, 618-626. doi:10.1086/339010
|
[14]
|
Sidikou, F., Djibo, S., Taha, M.K., Alonso, J.M., et al. (2003) Polymerase chain reaction assay and bacterial meningitis surveillance in remote areas, Niger. Emerging Infectious Diseases, 9, 1486-1488.
|
[15]
|
Chanteau, S., Sidikou, F., Djibo, S., Moussa, A., et al. (2006) Scaling up of PCR-based surveillance of bacterial meningitis in the African meningitis belt: Indisputable benefits of multiplex PCR assay in Niger. Transactions of the Royal Society of Tropical Medicine and Hygiene, 100, 677-680. doi:10.1016/j.trstmh.2005.09.006
|
[16]
|
Taha, M.K. (2000) Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. Journal of Clinical Microbiology, 38, 855-857.
|
[17]
|
Garcia, P., Garcia, J.L., Garcia, E. and Lopez, R. (1986). Nucleotide sequence and expression of the pneumococcal autolysin gene from its own promoter in Escherichia coli. Gene, 43, 265-272. doi:10.1016/0378-1119(86)90215-5
|
[18]
|
Falla, T.J., Crook, D.W., Brophy, L.N., Maskell, D., et al. (1994). PCR for capsular typing of Haemophilus influenzae. Journal of Clinical Microbiology, 32, 2382-2386.
|
[19]
|
Tzeng, Y.L., Noble, C. and Stephens, D.S. (2003) Genetic basis for biosynthesis of the (alpha 1→4)-linked N-acetyl-d-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X. Infection and Immunity, 71, 6712-6720. doi:10.1128/IAI.71.12.6712-6720.2003
|
[20]
|
Boisier, P., Nicolas, P., Djibo, S., Taha, M.K., et al. (2007) Meningococcal meningitis: Unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clinical Infectious Diseases, 44, 657-663.
doi:10.1086/511646
|
[21]
|
Gagneux, S., Wirth, T., Hodgson, A., Ehrhard, I., et al. (2002) Clonal groupings in serogroup X Neisseria meningitidis. Emerging Infectious Diseases, 8, 462-466.
|
[22]
|
Gesner, B.D., Mueller, J.E. and Yaro, S. (2010) African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults. BMC Infectious Diseases, 10, 10-22.
doi:10.1186/1471-2334-10-22
|
[23]
|
David, M.M., Guillermo, P., Judith, M., Charles, N., et al. (2009) Epidemiology and risk factors for serogroup X Meningococcal Meningitis during an outbreak in Western Kenya, 2005-2006. The American Journal of Tropical Medicine and Hygiene, 80, 619-624.
|
[24]
|
Etienne, J., Sperber, G., Adamou, A. and Picq, J.J. (1990) Epidemiologic notes: Meningococcal meningitis of serogroup X in Niamey (Niger). Médecine Tropicale, 50, 227-229.
|
[25]
|
Campagne, G., Schuchat, A., Djibo, S., Ousséini, A., et al. (1999) Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. Bulletin of the World Health Organ, 77, 499-508.
|
[26]
|
Leimkugel, J., Hodgson, A., Adams Forger, A., et al. (2007) Clonal waves of Neisseria colonization and disease in the African meningitis belt: Eight year longitudenal study in Northern Ghana. PLoS Medicine, 4, 0535-0544.
|
[27]
|
Materu, S., Cox, H.S., Isaakidis, P., Baruani, B., et al. (2007) Serogroup X in meningococcal disease, Western Kenya. Emerging Infectious Diseases, 13, 944-945.
doi:10.3201/eid1306.070042
|
[28]
|
Taha, M.K., Deghmane, A.E., Antignac, A., Zarantonelli, M.L., Larribe, M. and Alonso, J.M. (2002) The duality of virulence and transmissibility in Neisseria meningitidis. Trends Microbiology, 10, 376-382.
doi:10.1016/S0966-842X(02)02402-2
|
[29]
|
MacLennan, J.M., Urwin, R., Obaro, S., Griffiths, D., et al. (2000) Carriage of serogroup W-135, ET-37 meningococci in the Gambia: Implications for immunisation policy? The Lancet, 356, 1078.
doi:10.1016/S0140-6736(00)02734-3
|
[30]
|
Lingappa, J.R., Al-Rabeah, A.M., Hajjeh, R., Mustafa, T., et al. (2003) Serogroup W135 meningococcal disease during the Hajj, 2000. Emerging Infectious Diseases, 9, 665-671.
|
[31]
|
Traoré, Y., Njanpop-Lafourcade, B.M., Adjogble, K.L., Lourd, M., et al. (2006) The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clinical Infectious Diseases, 43, 817-822.
|
[32]
|
WHO (2007) Improved meningitis vaccine for Africa could signal eventual end to deadly scourge. Weekly Epidemiological Record, 24, 222-224.
|
[33]
|
Singleton, R.J., Hennessy, T.W., Bulkow, L.R., Hammitt, L.L., et al. (2007) Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. The Journal of the American Medical Association, 297, 1784-1792.
doi:10.1001/jama.297.16.1784
|